Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006
Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study Source: Eur Respir J 2004; 24: Suppl. 48, 187s Year: 2004
An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines? Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017
The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005
Potential economic savings of administration of home intravenous antibiotic therapy to patients with acute respiratory infections in Ireland Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Effect of C-reactive protein point of care testing and clinician communication skills training on antibiotic use and patient recovery in lower respiratory tract infections: a cluster randomised trial Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
The usage of laferon in treatment of patients with community acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Effect of educational courses on asthma management and treatment Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001
Antibiotic use and misuse in the community: how to manage the problem Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006
Efficacy and cost analysis of ceftriaxone 1 g versus aminopenicillin-betalactamase inhibitors in the treatment of pneumonia on general medical wards Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001
Cost-effectiveness of sequential iv-oral moxifloxacin versus current standard care in community acquired pneumonia to the Belgium health care system Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003
The effectiveness of urgent starting therapy of home pneumonia at the pre-hospital stage Source: Annual Congress 2009 - Pulmonary infections Year: 2009
A community-based intravenous medication service has proven to be safe, effective and cost-effective for patients with acute respiratory illness Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010
Long-term impact of DRIP score on antibiotic stewardship in patients with community acquired pneumonia Source: Virtual Congress 2021 – Pneumonia Year: 2021